A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
Clinical trial NCT06015737 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06015737
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-29
- Primary completion
- 2026-11-02
- Enrollment
- 339
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.